Is compounded semaglutide legit? What to check

'Is this legit?' is the right question to ask about compounded semaglutide, and the honest answer is: it can be, but it depends entirely on who's making it. Compounding is a legitimate, long-standing part of pharmacy — and it's also an area where quality varies more than with an FDA-approved product. Here's how to tell the difference without a pharmacy degree.

What compounding actually is

A compounding pharmacy prepares a medication tailored to a prescription rather than dispensing a mass-manufactured product. Compounded drugs are legal, but they are not FDA-approved — the agency does not review each compounded formulation for safety, effectiveness, or quality the way it does an approved drug¹. That single fact is why the pharmacy behind your medication matters so much: with a compounded product, its quality controls are doing the work the FDA approval process does for a brand.

503A vs 503B — the two kinds of compounder

Under federal law there are two categories. A 503A pharmacy compounds patient-specific prescriptions, typically at a traditional or telehealth-affiliated pharmacy scale. A 503B outsourcing facility registers with the FDA, is inspected on a risk-based schedule, and follows stricter manufacturing standards so it can produce larger batches¹. Neither makes an FDA-approved product, but a 503B operates under more oversight. If a provider names a 503B partner, that's a meaningful signal; if it names its pharmacy at all and explains the setup, that's already better than most.

Where the shortage rules fit

Much of the compounded GLP-1 market grew during the period when brand-name semaglutide was on the FDA shortage list, which gave compounders more latitude to make copies². As those shortages resolved, that latitude narrowed and regulatory attention increased. That doesn't make compounded semaglutide illegitimate — but it does mean the landscape is shifting, so a provider's compliance posture matters more than ever. The fuller story is in GLP-1 shortages and supply.

The checks that matter

Before you trust a compounded semaglutide desk, confirm a few things. Is it LegitScript-certified? LegitScript is an independent verification service, and its badge signals a provider has passed a compliance review — many of the desks we rate highly carry it. Does the provider name its 503A or 503B pharmacy partner, or at least explain its sourcing? For a sense of what a full answer looks like, Pallas Health names six dispensing pharmacies and publishes two prescribers' NPI numbers with a link to the federal registry to check them — the pharmacy list even explains the 503A/503B split rather than leaving you to work it out. That is unusual; most desks name nobody, and Oak is a plain example of what that looks like — its pages say only "Oak's contracted pharmacies" and "independent licensed physicians and nurse practitioners contracted through Oak's medical group partners", with no pharmacy, no clinician and no NPI published anywhere, while its own Terms, Privacy policy and checkout name three different operating companies between them. Is there a licensed clinician involved in prescribing, with a real health intake rather than a rubber-stamp form? Is your state served, and is licensing information available? And is the price stable and disclosed, or a teaser that hides the real cost? Our compounded semaglutide price and supply ranking shows which tracked desks currently pass that last test. A provider that answers those cleanly is playing it straight.

Red flags

Some signals should stop you. A desk that will not show you what it sells before you pay is near the top of the list: Lighter You publishes no product pages at all and gates its catalog behind a login, so the only way to learn what molecule, dose or format you are buying is to complete an intake — at which point you have already been charged. It is not a front, and it names four pharmacies with street addresses, which is more than most. But you cannot vet what you cannot read. No named pharmacy and no accreditation. Claims that a compounded product is 'FDA-approved' — it isn't, and saying so is a misrepresentation¹. 'Research-only,' gray-market, or unusually additive-laden formulations — this is exactly the category retatrutide falls into, since it has no FDA-approved reference product at all and, unlike semaglutide, cannot legally be compounded under federal law by any pharmacy, licensed or not. No clinician contact. And prices so far below the market that you should ask how the desk can possibly source safely at that number. The same molecule still carries the FDA's boxed warning about thyroid C-cell tumors and its contraindications — see what that warning actually means — so a desk that skips real screening is cutting a corner that matters³. A desk that also skips real GI screening is the same corner behind the ongoing GLP-1 gastroparesis litigation, which is worth understanding regardless of which pharmacy you use.

The bottom line

Compounded semaglutide from a properly licensed, accredited pharmacy with real clinical oversight is a legitimate option that many people use. Compounded semaglutide from an anonymous website with a suspiciously low price is a gamble. The difference is entirely in the checks above — run them with our 5-minute provider checklist, understand how it compares to the brand in compounded vs brand-name GLP-1, and see which desks we score highest in our provider briefs. This is guidance for vetting a provider, not medical advice; your prescriber is the right person for decisions about your care.